SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology is trending following a Cornell University study validating its APU's performance and energy efficiency relative to GPUs, sparking excitement about its potential in AI. The community is discussing the possibility of a buyout, comparing it to other AI plays, and debating whether its potential justifies the current valuation. Some traders are wary of potential dilution while others are optimistic about a multi-day run.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG, Bitcoin's meme token, is trending as community members tout its strong fundamentals, fair distribution, and growing ecosystem on the Bitcoin blockchain.  focus on the coin's potential to onboard millions to Bitcoin and its unique position as a meme asset secured by Bitcoin's network. The community, known as the 'DOG Army,' emphasizes its organic growth and dedication to decentralization.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

GLXY is trending as investors eagerly await earnings, with community chatter focused on a potential beat driven by AI data center prospects and crypto market recovery. Discussions also involve a recently announced strategic investment from a leading asset management firm, with speculation around who the investor is. Some traders are expressing concern about short-term dilution, while others are focused on the long-term potential of GLXY's diversified business model.

Zions Bancorporation NA is a bank holding company, which engages in the provision of full banking and related services. It operates through the following segments: Zions Bank, Amegy Bank, California Bank & Trust, National Bank of Arizona, Nevada State Bank, Vectra Bank Colorado, and The Commerce Bank of Washington. The company was founded on February 17, 1961, and is headquartered in Salt Lake City, UT.

Zions Bancorporation N.A

Zions Bancorp is trending due to Q3 earnings exceeding expectations, with investors seemingly shrugging off a prior charge-off tied to bad loans that previously rattled the market. The community is actively discussing the bank's bounce-back, with some analysts suggesting the selloff was overdone, while others highlight concerns about credit risks in the broader regional banking sector. Community members are watching ZION's ability to maintain its credit without concerns of risk weighted assets and charge offs.

Abercrombie & Fitch Co. engages in the retail of apparel, personal care products, and accessories. The firm operates through following geographical segments: Americas, EMEA and APAC. The Americas segment includes operations in North America and South America. The EMEA segment includes operations in Europe, the Middle East and Africa. The APAC segment includes operations in the Asia-Pacific region, including Asia and Oceania. The company was founded by David Abercrombie in 1892 and is headquartered in New Albany, OH.

Abercrombie & Fitch Co. - Ordinary Shares - Class A

Abercrombie & Fitch Co.

Abercrombie & Fitch is trending as community members debate whether the stock's recent pullback represents a buying opportunity, citing oversold conditions and strong financials, or if concerns about future growth are warranted. Discussions also focus on the potential for a short squeeze, given the high short interest, and the impact of broader market and sector trends on ANF's performance. Some traders are closely watching technical indicators and key support levels for signs of a reversal.

FLOKI is the utility token of the Floki Ecosystem. The Floki Ecosystem is a community-powered ecosystem that aims to give people control of their finances through four key utility offerings:  - The Valhalla NFT Metaverse Game. - The Floki University Crypto Education platform. - DeFi. - The FlokiPlaces NFT & Merchandise Marketplace.

Floki Token

FLOKI is trending due to its recent listing on Robinhood, sparking excitement within the community about increased accessibility and potential price surge. Community members are drawing comparisons to DOGE and SHIB, while anticipating a potential rally. Some traders are actively scalping the volatility, while longer-term holders express optimism about the future.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending due to recent positive preliminary Q3 results and raised FY2025 revenue guidance, sparking community discussion around a potential short squeeze given the high short interest. Some investors speculate about a possible acquisition by larger pharmaceutical companies and the potential impact of CorMedix's investment in TLPH, while others focus on the upcoming earnings report and potential catalysts.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending due to a widespread AWS outage impacting numerous websites and applications, sparking community discussion about the company's infrastructure and potential lawsuits. Despite the service disruption, the stock price saw an increase, fueling debates about market dynamics and AWS's overall importance. Some investors believe the outage highlights the world's dependence on Amazon, while others anticipate a negative impact on earnings and a potential shift to alternative cloud providers.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending as the company explores rare earth mineral production, potentially transforming it into a strategic metals player amid tightening export controls from China. This pivot is sparking discussions about the company's growth potential beyond steel, with some seeing it as a smart move while others question execution and debt. Community members are closely monitoring its Q3 earnings report to determine if it can meet expectations.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastem ($VSTM) is trending due to promising data from a partner's lung cancer drug trial in China, which is driving optimism despite some investors expressing caution and pointing to past volatility. The community is actively discussing the implications of the trial results, potential for a short squeeze, and management's handling of the company. Discussions also include comparisons to competitors and the potential for a buyout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

How Will DefenCath Aid CRMD's Top Line in the Upcoming Q3 Results?

CorMedix's DefenCath, the first FDA-approved antimicrobial catheter lock, is expected to drive Q3 growth as new Melinta drugs add to momentum.

<ul class="summary-bullets"><li>CorMedix said it was raising its fiscal 2025 pro forma net revenue guidance to at least $375 million.</li><li>The company said the third-quarter unaudited DefenCath net revenue came in at more than $85 million.</li><li>DefenCath is a drug used for the prevention of catheter-related bloodstream infections in adult patients undergoing hemodialysis via a central venous catheter.</li></ul>CorMedix Inc. (CRMD) stock became the top trending ticker on Stocktwits after the shares jumped 12% in premarket trading following the biopharmaceutical company raising its annual net revenue forecast on Monday.The company said it was raising its fiscal 2025 pro forma net revenue guidance to at least $375 million, up from a prior forecast of $325 million to $350 million.<h2 class="st-heading-2">What Is The Company’s Expectation For Q3?</h2>CorMedix said that preliminary third-quarter unaudited results showed net revenue of more than $100 million, including at least $85 million for DefenCath, and preliminary pro forma third-quarter unaudited company net revenue of more than $125 million.CorMedix has been working on DefenCath (taurolidine and heparin) for the prevention of catheter-related bloodstream infections in adult patients undergoing hemodialysis via a central venous catheter.The company said DefenCath revenue growth has been driven by stronger-than-projected utilization by the company’s Large Dialysis Organization (LDO) customer, as well as continued utilization growth with other customers.Get updates to this developing story directly on Stocktwits.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/delta-united-airlines-affected-by-aws-disruption-report/ch6CMB4R3Yi">Delta, United Airlines Affected By AWS Disruption: Report</a>

CRMD Stock Is The Talk Of The Town Today: What’s The Latest 2025 Revenue Forecast?

CorMedix said it was raising its fiscal 2025 pro forma net revenue guidance to at least $375 million.

Equity

Astria Therapeutics Stock Rallies 37% on $700M Buyout Offer From BCRX

ATXS stock jumps 37% after agreeing to a $700 million cash-and-stock buyout by BioCryst, boosting the latter's HAE treatment pipeline.

CorMedix Stock Plunges 16% in a Month: Should Investors Buy the Dip?

CRMD shares slip 16%, but rising DefenCath sales and the Melinta deal can set the stage for renewed growth.

FDA Extends Review of DNLI's Hunter Syndrome Drug by Three Months 

Denali Therapeutics faces an FDA review delay for its Hunter syndrome drug, pushing potential approval of tividenofusp alfa to April 2026.


Will CorMedix's DefenCath Edge Last If Bigger Heparin Rivals Close In?

CRMD's DefenCath gives the company a first-mover edge in CRBSI prevention, but looming heparin giants test how long its lead can last.

GMAB Stock Soars 21.9% in a Month Following MRUS Acquisition Deal

Genmab stock surges 21.9% after striking an $8 billion deal to buy Merus, adding a late-stage cancer treatment candidate to its proprietary oncology pipeline.

ILMN Stock Set to Benefit From the Launch of New BioInsight Division

Illumina launches BioInsight to harness multiomic data, accelerate drug discovery, and boost disease diagnosis.

ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves

AngioDynamics posts narrower-than-expected Q1 loss, 12% revenue growth and margin gains; it also raises FY26 sales outlook, sending shares higher.

CDTX Stock Soars 218% YTD on Positive Updates From Influenza Program

Cidara Therapeutics' shares surge 218% this year after its flu candidate CD388 hits key mid-stage study goals and advances into pivotal testing.

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$12.12
Prev Close	$10.18
Open	$11.78
Dividend Yield	0.00%
50-Day Moving Average	$12.10
Beta	1.05
Avg. Volume	4.41M
PE Ratio	13.63

52-Week High	$17.43
52-Week Low	$5.60
Market Capitalization	$794.64M
EPS (Annual)	-$0.3046
Price to Book	3.44
Revenue Per Employee	$668,802.61
Enterprise Value/EBITDA	N/A

CRMD
CorMedix Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CRMD News

CRMDCorMedix Inc